Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

1. Sverrild, A.
2. Cerps, S.
3. Nieto-Fontarigo, J.J.
4. Ramu, S.
5. Hvidtfeldt, M.
6. Menzel, M.
7. Kearley, J.
8. Griffiths, J.M.
9. Parnes, J.R.
10. Porsbjerg, C.
11. Uller, L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/ALL.15918 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus